Future oncology (London, England) 2016-03
Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?
Related Questions
What is your preferred dose and fractionation? Do you utilize 4D simulation? Additionally, how conservative are your constraints for ipsilateral uninv...
New comment by Radiation Oncologist at Jacob E Locke MD PA ( July 9, 2021)
What regimen for small nodular recurrence post nephrectomy in the surgical bed is suggested?